Dermaliq
Next-generation topical drug therapies for skin and follicular diseases
Wilmington, United States · Founded 2021 · $15.0M raised
- Headquarters
- Wilmington, Delaware
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- dermaliq.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Series AJan 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Dermaliq Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company founded in 2021 as a spin-off from Novaliq GmbH to advance novel topical drug therapies in dermatology. The company's proprietary hyliQ™ technology platform enables cutaneous drug delivery with superior bioavailability compared to conventional topical formulations. Dermaliq's pipeline includes DLQ01 (topical androgenetic alopecia treatment targeting PGE2 receptors), DLQ02 (calcineurin inhibitor for plaque psoriasis), and DLQ03 (broad-spectrum topical antibiotic for skin and soft tissue infections). The company raised a USD 15 million Series A in January 2022 co-led by 3E Bioventures Capital and Beijing Whale Technology. Dermaliq is incorporated in Wilmington, Delaware and led by CEO Dr. Frank Löscher.
Summary
Dermaliq is a Biotech company based in Wilmington, United States, founded in 2021. It has raised $15.0M in total across 1 round, most recently a $15.0M Series A round in Jan 2022. Investors include 3E Bioventures Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dermaliq"><img src="https://indexed.vc/api/badge/company/dermaliq" alt="Dermaliq on Indexed.vc" width="260" height="76" /></a>